Multiomics Machine Learning to Predict Neoadjuvant Chemotherapy Outcome and Relapse of Breast Cancer

<b>Objective:</b> The aim of this study was to investigate multiomics (MO) integration with stacked-ensemble learning for predicting neoadjuvant chemotherapy (NAC) response and recurrence risk in breast cancer (BC). <b>Impact Statement:</b> This study demonstrates that a stacked-ensemble learning model integrating clinicopathologic and magnetic resonance imaging (MRI)-based intratumoral heterogeneity biomarkers effectively predicts NAC response and postoperative recurrence risk in BC patients. These findings underscore MO and machine learning's potential to optimize clinical decision-making. <b>Introduction:</b> Selecting BC patients who will benefit from NAC remains challenging. <b>Methods:</b> We retrospectively analyzed 124 BC patients receiving NAC (3 to 8 cycles) prior to mastectomy. Two radiomics signatures-RadS<sub>ET</sub> and RadS<sub>ITH</sub>-were derived from pre-NAC high-resolution dynamic MRI to track entire-tumor and intratumoral heterogeneous characteristics, respectively. These signatures were integrated with clinicopathologic indicators using stacked-ensemble learning algorithms to predict pathological complete response (pCR) and 3-year disease-free survival (DFS). <b>Results:</b> Among the 124 patients, the pCR rate was 26.6%. For pCR prediction, RadS<sub>ITH</sub> and RadS<sub>ET</sub> yielded areas under the curve (AUCs) of 0.798 and 0.770, respectively. The MO-integrated model, combining RadS<sub>ITH</sub>, RadS<sub>ET</sub>, clinical N stage, and molecular subtype, achieved a significantly higher AUC (0.917; 95% confidence interval [CI], 0.860 to 0.958; <i>P</i> < 0.05) than individual models. Postoperative recurrence occurred in 13.6% of patients. The elastic-net Cox model achieved a DFS concordance index of 0.78 (95% CI, 0.72 to 0.83) using pre-NAC variables (MO-predicted pCR, Response Evaluation Criteria in Solid Tumors response, RadS<sub>ITH</sub>), and 0.81 (95% CI, 0.76 to 0.92) with post-NAC variables (pathologic grade, pCR status, pT stage, and pN stage). <b>Conclusion:</b> The MO integration with stacked-ensemble learning effectively predicts NAC response and recurrence risk in BC.

Authors

Institutions

Publication Details

Journal
BME Frontiers
Published
2025-12-03
DOI
https://doi.org/10.34133/bmef.0212
Primary Topic
Radiomics and Machine Learning in Medical Imaging
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Multiomics Machine Learning to Predict Neoadjuvant Chemotherapy Outcome and Relapse of Breast Cancer

Xianhe Xie, Lili Wang, Xiaodong Zhang, Ying Chen et al.
BME Frontiers
Radiomics and Machine Learning in Medical Imaging
article

Multiomics Machine Learning to Predict Neoadjuvant Chemotherapy Outcome and Relapse of Breast Cancer

Xianhe Xie, Lili Wang, Xiaodong Zhang, Ying Chen, Jian Li, Jing Zhang, Weiwei Huang
article en

Abstract

<b>Objective:</b> The aim of this study was to investigate multiomics (MO) integration with stacked-ensemble learning for predicting neoadjuvant chemotherapy (NAC) response and recurrence risk in breast cancer (BC). <b>Impact Statement:</b> This study demonstrates that a stacked-ensemble learning model integrating clinicopathologic and magnetic resonance imaging (MRI)-based intratumoral heterogeneity biomarkers effectively predicts NAC response and postoperative recurrence risk in BC patients. These findings underscore MO and machine learning's potential to optimize clinical decision-making. <b>Introduction:</b> Selecting BC patients who will benefit from NAC remains challenging. <b>Methods:</b> We retrospectively analyzed 124 BC patients receiving NAC (3 to 8 cycles) prior to mastectomy. Two radiomics signatures-RadS<sub>ET</sub> and RadS<sub>ITH</sub>-were derived from pre-NAC high-resolution dynamic MRI to track entire-tumor and intratumoral heterogeneous characteristics, respectively. These signatures were integrated with clinicopathologic indicators using stacked-ensemble learning algorithms to predict pathological complete response (pCR) and 3-year disease-free survival (DFS). <b>Results:</b> Among the 124 patients, the pCR rate was 26.6%. For pCR prediction, RadS<sub>ITH</sub> and RadS<sub>ET</sub> yielded areas under the curve (AUCs) of 0.798 and 0.770, respectively. The MO-integrated model, combining RadS<sub>ITH</sub>, RadS<sub>ET</sub>, clinical N stage, and molecular subtype, achieved a significantly higher AUC (0.917; 95% confidence interval [CI], 0.860 to 0.958; <i>P</i> < 0.05) than individual models. Postoperative recurrence occurred in 13.6% of patients. The elastic-net Cox model achieved a DFS concordance index of 0.78 (95% CI, 0.72 to 0.83) using pre-NAC variables (MO-predicted pCR, Response Evaluation Criteria in Solid Tumors response, RadS<sub>ITH</sub>), and 0.81 (95% CI, 0.76 to 0.92) with post-NAC variables (pathologic grade, pCR status, pT stage, and pN stage). <b>Conclusion:</b> The MO integration with stacked-ensemble learning effectively predicts NAC response and recurrence risk in BC.

BME FrontiersVol. 7
Fujian Medical University (CN), Peking University (CN), First Affiliated Hospital of Fujian Medical University (CN), Peking University First Hospital (CN), Fujian Provincial Cancer Hospital (CN)
Openalex Percentile: Top 47%
Radiomics and Machine Learning in Medical Imaging
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.